Skip to main content
main-content

Zeitschrift

Virchows Archiv

European Journal of Pathology

insite
SUCHEN

Virchows Archiv OnlineFirst articles

16.05.2022 | Original Article

5-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsies

The differentiation between reactive mesothelial hyperplasia (RMH) and diffuse malignant peritoneal mesothelioma (DMPM) is challenging especially when applied on peritoneal small samples. The use of BRCA-associated protein 1 (BAP1) and …

14.05.2022 | Review

The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS

Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive epithelial cells characterized by loss or functional alteration of E-cadherin-mediated cell adhesion. The morphologic spectrum of LCIS encompasses classic …

13.05.2022 | Original Article

The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance

We assessed the value of cytokeratin 17 (CK17) expression for the differential diagnosis between primary ovarian mucinous tumors and metastases from the gastrointestinal tract (GIT) and the significance of CK17 expression in a broad spectrum of …

09.05.2022 | Original Article

Cancerization of ducts in hilar cholangiocarcinoma

Invasive cancers that arise from ductal structures can infiltrate and colonize pre-existing ducts in a process referred to as cancerization of ducts (COD). COD in cholangiocarcinoma is an under-studied process whose clinical significance remains …

09.05.2022 | Brief Report

Identification of a novel translocation producing an in-frame fusion of TAF15 and ETV4 in a case of extraosseous Ewing sarcoma revealed in the prenatal period

Ewing sarcoma (ES) is a highly malignant round cell sarcoma, characterized by gene fusion involving FET (FUS, EWSR1, TAF15) and ETS family genes, respectively. The involvement of the EWSR1 gene has been reported in approximately 90% of cases of …

Aktuelle Ausgaben

Über diese Zeitschrift

The Official Journal of the European Society of Pathology

Mission statement: To advance the scientific basis of human pathology by the publication (encouragement and dissemination) of high quality research (including molecular and translational studies) and thereby contribute to patient care.

Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.

Metadaten
Titel
Virchows Archiv
Abdeckung
Volume 430/1997 - Volume 480/2022
Verlag
Springer Berlin Heidelberg
Elektronische ISSN
1432-2307
Print ISSN
0945-6317
Zeitschriften-ID
428
DOI
https://doi.org/10.1007/428.1432-2307

Neu im Fachgebiet Pathologie

25.04.2022 | Riesenzelltumor | Schwerpunkt: Connective (tissue) pathology: Was uns verbindet!

Riesenzell-haltige Tumoren des Knochens und Differenzialdiagnosen

24.04.2022 | Schwerpunkt: Connective (tissue) pathology: Was uns verbindet!

Automatisierung und Einsatz von Robotern im Pathologielabor

12.04.2022 | Schwerpunkt: Connective (tissue) pathology: Was uns verbindet!

Praktisch-diagnostische Aspekte uteriner Leiomyosarkome im Kontext der WHO-Klassifikation 2020

11.04.2022 | Schwerpunkt: Connective (tissue) pathology: Was uns verbindet!

Künstliche Intelligenz als Lösung des PathologInnenmangels?